Algorithme Pharma Announces the Appointment of an Executive Vice President, Phase I Clinical Development
Algorithme Pharma of the Altasciences Group, a full service provider focused on early stage clinical research, today announced the addition of Dr. Graham Wood, Executive Vice President, Phase I Clinical Development to the team.
Two Altasciences Executives Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
Altasciences, a provider of top tier customer-tailored early phase clinical trial services, is pleased to announce that Chris Perkin, CEO at Altasciences, and his colleague, Dr. Brad Vince, CEO and Medical Director at Vince & Associates Clinical Research, an Altasciences company, have been named two of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine.
Algorithme Pharma, a full service provider focused on early stage clinical research with over twenty years of experience, proudly announces the addition of Dr. Anahita Keyhani to the Algorithme Pharma family. Dr. Keyhani brings almost two decades of experience to her new role as Director, Method Development, previously Senior Research Scientist at Charles River Laboratories.
Algorithme Pharma, an Altasciences company, is now a proud member of the Clinical Data Interchanges Standards Consortium (CDISC), a non-profit organization harmonizing clinical data and streamlining research processes, from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data.
Altasciences is pleased to announce that its companies, Algorithme Pharma (Montreal, Canada) and Vince & Associates Clinical Research (Kansas, USA), are both 2015 CRO Leadership Award recipients.